Published in Lab Business Week, June 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Geron.
Report 2: Geron Corporation (GERN) announced the presentation of new data that document the company's progress in the development of first-in-class therapeutic products from human embryonic stem cells (hESCs) for the treatment of degenerative diseases.
Presented by Geron scientists and collaborators at the International Society for Stem Cell Research's (ISSCR) annual meeting in Toronto, the data pertained to four products in development: (1)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.